FOCL · Edap Tms SA
$4.76
+0.13 (+2.81%)
At close · Aug 14
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 7, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$178.41M
Shares
37.53M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.76
Open$4.51
Day$4.51–4.78
52W close$1.35–6.34
Avg vol 30d119K
Short int256K · 0.7% float · 4.3d
Short vol36%
Last earningsAug 13, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 14
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+20%
above
Price vs 50-day avg
−11%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
68%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−13%
trailing
6-month return
+5%
trailing
YTD return
+45%
this year
Relative strength
−8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.68% of float · ▲ +9.4% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
38 holders — mid 3-yr range
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
+2%
Y/Y
Gross margin
43%
expanding
EPS growth
−42%
Y/Y
Balance sheet
$2.5M
net cash
Quant / Vol
risk profile
Volatility
88%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
6.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 13, 2026
Total revenue
· 2026
$50M – $54M
prior FY $70.53M
midpoint −26.3% Y/Y
Prior guidance
period ended
· from the 8-K filed Aug 11, 2026
Gross Margin
· second quarter of 2026
54% – 56%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+20%
Bullish
Price vs 50-day avg
−11%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
68%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.68% of float · ▲ +9.4% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
38 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $5 · 68%
Range high $6
vs 200-day avg +20%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Focal One Capital System Sales | 13 | Q2 2026 | — |
| Focal One System Installed Base | 184 | Q2 2026 | — |
| Focal One System Installed Base (International) | 88 | Q2 2026 | — |
| Focal One System Installed Base (U.S.) | 96 | Q2 2026 | — |
| Focal One system placements year-over-year growth | 44% | Q2 2026 | — |
| Gross Margin | 55.6% | Q2 2026 | — |
| U.S. Procedure Volume Growth | 47% | Q2 2026 | — |
| Focal One Systems as of Dec. 31, 2025 | 41 | as of Dec. 31, 2025 | — |
| Focal One Treatment Clinical Sites | 254 | as of Dec. 31, 2025 | — |
| Focal One system placements YoY growth | 83% | first quarter of 2026 | — |
| U.S. Focal One procedures YoY growth | 53% | first quarter of 2026 | — |
| Worldwide disposables revenue YoY growth | 54% | first quarter of 2026 | — |
| Focal One HIFU procedures growth (U.S.) | 28% | the fourth quarter of 2025 | — |
| Focal One system placements | 15 | the fourth quarter of 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FOCL
this stock
Edap Tms SA
|
$178.41M | +44.7% | +1.6% | — | 0.7% |
|
MCK
Mckesson Corp
|
$101.32B | +5.9% | +3.1% | 23.3 | 3.1% |
|
COR
Cencora, Inc.
|
$59.89B | -7.1% | +9.3% | 23.3 | 2.7% |
|
CAH
Cardinal Health Inc
|
$54.69B | +14.4% | +14.2% | — | 2.8% |
|
HSIC
Henry Schein Inc
|
$10.00B | +18.8% | +5.9% | 26.2 | 5.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FOCL | -23.5% | -12.5% | +5.3% | -22.2% | +44.7% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -23.9% | -17.0% | -8.5% | -26.1% | +30.8% |
Key facts
CIK
1041934
CUSIP
268311107
13F (30d)
37 filings
37 filers
Visit website
Investor relations